Cambridge Innovation Capital (Jersey) Ltd 4

4 · BICYCLE THERAPEUTICS plc · Filed May 31, 2019

Form 4

Period: 2019-05-28

10% Owner

Transactions

Conversion
Ordinary Shares
[F1]
2019-05-28+1,081,823→ 1,081,823 total
Exercise of In-Money
Ordinary Shares
[F1]
2019-05-28+125,587→ 1,207,410 total
Conversion
Ordinary Shares
[F1]
2019-05-28+229,741→ 1,437,151 total
Purchase
Ordinary Shares
2019-05-29$14.00/sh+314,286$4,400,004→ 1,751,437 total
Conversion
Series B1 Preferred Shares
[F1]
2019-05-28−1,081,823→ 0 total
→ Ordinary Shares (1,081,823 underlying)
Exercise of In-Money
Series B1 Preferred Shares Warrants
[F2][F1]
2019-05-28−125,587→ 0 total
→ Ordinary Shares (125,587 underlying)
Conversion
Series B2 Preferred Shares
[F1]
2019-05-28−229,741→ 0 total
→ Ordinary Shares (229,741 underlying)

Footnotes (2)

[F1]Each Series B1 and B2 Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.
[F2]Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.

Signature

/s/ Rob Sprawson By: Rob Sprawson Its: Director|2019-05-31

Documents

1 file